![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
Synthon B.v. Nijmegen Nl, based in Netherlands, is a pharmaceutical company that stands out with its certifications from FDA.
One of their significant offerings is Pemetrexed disodium 2.5-hydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-272 - Rev 01
This Chemical Type CEP, issued on March 01, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 3046 associated with this CEP further emphasizes